Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Inventiva
  6. News
  7. All News
    IVA   FR0013233012

INVENTIVA

(IVA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
All news about INVENTIVA
07/22INVENTIVA : Half-yearly review of the liquidity contract with Kepler Cheuvreux
PU
07/22INVENTIVA : Half-Year Review of Inventiva's Liquidity Contract with Kepler Cheuv..
GL
07/20INVENTIVA : Half-Year Review of Inventiva's Liquidity Contract with Kepler Cheuv..
PU
07/02INVENTIVA : Corporate Presentation July 2021
PU
06/15INVENTIVA TO PARTICIPATE AT THE SVB : Liver Disease Day
GL
06/09Inventiva announces three scientific presentations at the EASL International ..
GL
05/25INVENTIVA : to participate at the Jefferies Virtual Healthcare Conference
GL
05/14INVENTIVA : reports first quarter 2021 financial information and updates on the ..
PU
05/13GLOBAL MARKETS LIVE : Walt Disney, Canada Goose, Tod's, Burberry, Sonos...
05/13INVENTIVA : AbbVie to Initiate Phase 2B Study of Autoimmune Disease Drug
MT
05/12Inventiva reports first quarter 2021 financial information and updates on the..
GL
05/12INVENTIVA : reports first quarter 2021 financial information and updates on the ..
GL
05/12Inventiva Reports Financial Results for the First Quarter Ended March 31, 202..
CI
05/12Inventiva Updates on the Collaboration with Abbvie in Auto-Immune Diseases
CI
04/26INVENTIVA : to participate at the 7th Annual Truist Securities Life Sciences Sum..
AQ
04/26INVENTIVA : to participate at the 7th Annual Truist Securities Life Sciences Sum..
GL
04/20INVENTIVA : Appointment of Martine Zimmermann as Independent Director to Inventi..
AQ
04/19Inventiva S.A. Announces Board Changes
CI
04/19Appointment of Martine Zimmermann as Independent Director to Inventiva's Boar..
GL
04/19INVENTIVA : Results of the votes of the Combined Shareholders' Meeting of April ..
AQ
04/07INVENTIVA : Corporate Presentation April 2021
PU
03/26INVENTIVA : - Shareholders Meeting of April 16, 2021, Availability of the prepar..
AQ
03/25INVENTIVA S A : Shareholders Meeting of April 16, 2021 – Availability of t..
PU
03/25INVENTIVA S A : Combined Shareholders Meeting of April 16, 2021 - Availability o..
GL
03/24INVENTIVA S A : Amendment to Annual Report by Foreign Issuer (SEC Filing - 20-F/..
PU
03/16INVENTIVA S A : Annual Report (SEC Filing - 20-F)
PU
03/15INVENTIVA S A : announces filing of its 2020 Universal Registration Document and..
GL
03/08INVENTIVA S A : Societe Generale Downgrades Inventiva to Sell Rating From Buy
MT
03/04Inventiva S.A. Announces Earnings Results for the Year Ended December 31, 202..
CI
03/042020 FULL-YEAR RESULTS : Major advances in NASH and significantly extended cash ..
GL
02/26INVENTIVA : announces collaboration on non-invasive biomarkers to identify patie..
AQ
02/25INVENTIVA S A : announces collaboration on non-invasive biomarkers to identify p..
GL
02/25Inventiva Announces Collaboration on Non-Invasive Biomarkers to Identify Pati..
CI
02/24INVENTIVA S A : announces collaboration on non-invasive biomarkers to identify p..
PU
02/24INVENTIVA S A : to participate at several investor conferences in March 2021
GL
02/24INVENTIVA : 's 2020 Full-Year Financial Results Presentation
AQ
02/23INVENTIVA S A : 2020 Full-Year Financial Results Presentation
GL
02/11FULL-YEAR 2020 : Cash position and revenues
GL
02/11Inventiva S.A. Announces Revenue Results for the Year 2020
CI
02/09INVENTIVA S A : A statement of beneficial ownership of common stock by certain p..
PU
02/01INVENTIVA S A : Corporate Presentation February 2021
PU
01/15INVENTIVA S A : Half-Year Review of Inventiva's Liquidity Contract with Kepler C..
AQ
01/06INVENTIVA S A : to present at the 39th Annual J.P. Morgan Healthcare Conference
PU
01/06INVENTIVA S A : annonce sa participation à la ź 39th Annual J.P. Morgan Healthca..
GL
01/06INVENTIVA S A : Présentation corporate janvier 2021
PU
01/06INVENTIVA S A : to Kick Off Phase Three Trial for Lanifibranor in Non-Alcoholic ..
MT
01/05INVENTIVA S A : Moving Ahead With Phase III Trial of Prospective Treatment for L..
MT
01/05Inventiva announces design of Phase III clinical trial with lanifibranor in N..
GL
01/05Inventiva Announces Design of Phase III Clinical Trial with Lanifibranor in N..
CI
2020INVENTIVA S A : announces the publication in the Journal of Hepatology of new pr..
GL
2020Inventiva Announces the Publication in the Journal of Hepatology of New Pre-C..
CI
2020INVENTIVA : to participate at the Piper Sandler 32nd Annual Virtual Healthcare C..
AQ
2020INVENTIVA : to participate at the Piper Sandler 32nd Annual Virtual Healthcare C..
AQ
2020INVENTIVA S A : to participate at the Piper Sandler 32nd Annual Virtual Healthca..
GL
2020INVENTIVA : - Q3 2020 Financial Information
AQ
2020INVENTIVA S A : Q3 2020 Revenues and Cash Position
PU
2020INVENTIVA S A : Q3 2020 Financial Information
PU
2020INVENTIVA S A : Q3 2020 Financial Information
AQ
2020INVENTIVA S A : Q3 2020 Financial Information
AQ
2020INVENTIVA S A : Q3 2020 Financial Information
GL
2020Inventiva S.A. Reports Revenue Results for the Nine Months Ended September 30..
CI
2020Q3 2020 Financial Information
GL
2020INVENTIVA : receives positive FDA feedback to advance its lead drug candidate la..
AQ
2020INVENTIVA S A : FDA Backs Inventiva's Plan to Advance Lead Non-Alcoholic Fatty L..
MT
2020Inventiva S.A. Receives Positive Fda Feedback to Advance Its Lead Drug Candid..
CI
2020INVENTIVA S A : receives positive FDA feedback to advance its lead drug candidat..
PU
2020INVENTIVA : receives positive FDA feedback to advance its lead drug candidate la..
AQ
2020INVENTIVA : receives positive FDA feedback to advance its lead drug candidate la..
AQ
2020INVENTIVA S A : receives positive FDA feedback to advance its lead drug candidat..
GL
2020Inventiva receives positive FDA feedback to advance its lead drug candidate l..
GL
2020INVENTIVA : to participate at the Stifel Virtual Healthcare Conference 2020 and ..
AQ
2020INVENTIVA S A : to participate at the Stifel Virtual Healthcare Conference 2020 ..
GL
2020Inventiva to participate at the Stifel Virtual Healthcare Conference 2020 and..
GL
2020INVENTIVA S A : announces the appointment of Dr. Michael Cooreman as Chief Medic..
PU
2020INVENTIVA : announces the appointment of Dr. Michael Cooreman as Chief Medical O..
AQ
1  2  3  4  5Next
Upcoming event on INVENTIVA
07/28/21